| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | Dec 4, 2020 | Y-mAbs Therapeutics, Inc. | CEO | Sell | 17.5 | -50,000 | -7.41% | ✗ | $2.6M |
| May 13, 2020 | May 15, 2020 | Y-mAbs Therapeutics, Inc. | CEO | Sell | 16.3 | -200,000 | -22.86% | ✗ | $7.3M |
| Mar 17, 2020 | Mar 19, 2020 | Y-mAbs Therapeutics, Inc. | CEO | Buy | 61.3 | +1,900 | 0.22% | ✗ | $32.7K |
| Sep 25, 2018 | Sep 25, 2018 | Y-mAbs Therapeutics, Inc. | CEO | Buy | 85.0 | +31,250 | 1.82% | ✗ | $500K |